61618-27-7 | Sodium 2-(2-amino-3-benzoylphenyl)acetate hydrate

Packsize	Purity	Availability	Price	Discounted Price
10mg	97%	in stock	$9.00	$6.00
50mg	97%	in stock	$13.00	$9.00
1g	97%	in stock	$36.00	$25.00
5g	97%	in stock	$119.00	$83.00
25g	97%	in stock	$399.00	$279.00

Description

• Catalog Number: AI53734
• Chemical Name: Sodium 2-(2-amino-3-benzoylphenyl)acetate hydrate
• CAS Number: 61618-27-7
• Molecular Formula: C15H14NNaO4
• Molecular Weight: 295.2657
• MDL Number: MFCD09842317
• SMILES: [O-]C(=O)Cc1cccc(c1N)C(=O)c1ccccc1.[Na+].O

Computed Properties

• Complexity: 342
• Covalently-Bonded Unit Count: 3
• Heavy Atom Count: 21
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 4

Literature

• Randomized clinical trial of treatment for TMJ disc displacement.

  Journal of dental research 20101101

• The effects of nepafenac and amfenac on retinal angiogenesis.

  Brain research bulletin 20100215

• Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress.

  Archives of biochemistry and biophysics 20091001

• Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.

  Journal of cataract and refractive surgery 20080801

• Amfenac increases the radiosensitivity of uveal melanoma cell lines.

  Eye (London, England) 20080501

• In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.

  Journal of cataract and refractive surgery 20070901

• The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines.

  Eye (London, England) 20060501

• Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.

  Inflammation 20000801